Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inversion of (R)- to (S)-ketoprofen in eight animal species

G Aberg1, V B Ciofalo, R G Pendleton

  • 1Sepracor, Inc., Marlborough, MA 01752, USA.

Chirality
|January 1, 1995
PubMed
Summary

Researchers investigated how different animal species convert the inactive (R)-form of the painkiller ketoprofen into the active (S)-form. They found that all eight tested species performed this conversion, effectively turning the drug into a prodrug that provides pain relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flexed elbow, abducted shoulder, forearm supinated (FABS) reconstruction from three-dimensional elbow MRI: diagnostic performance assessment in biceps head anatomy and pathology.

Clinical radiology·2024
Same author

Reduction of smoking urges with intranasal insulin: a randomized, crossover, placebo-controlled clinical trial.

Molecular psychiatry·2017
Same author

Multistate outbreak of listeriosis caused by imported cheese and evidence of cross-contamination of other cheeses, USA, 2012.

Epidemiology and infection·2015
Same author

Dietary factors and cancer chemoprevention: an overview of obesity-related malignancies.

Journal of postgraduate medicine·2009
Same author

Interline Transfer CCD Camera for Gated Broadband Coherent Anti-Stokes Raman-Scattering Measurements.

Applied optics·2008
Same author

Epidemiologic features of gastric cancer in a railway population in eastern India.

The Journal of the Association of Physicians of India·2007

Area of Science:

  • Pharmacokinetics research within (R)-ketoprofen metabolic studies
  • Comparative pharmacology and toxicology

Background:

No prior work had resolved the full extent of interspecies variation regarding the metabolic conversion of specific non-steroidal anti-inflammatory drug enantiomers. It was already known that chiral inversion represents a unique pharmacokinetic pathway for certain arylpropionic acid derivatives. That uncertainty drove researchers to examine how diverse biological systems process these distinct molecular configurations. Prior research has shown that metabolic pathways often diverge significantly between mammalian models and human subjects. This gap motivated a systematic evaluation of how the (R)-enantiomer behaves when introduced into various physiological environments. Scientists previously identified that some isomers lack direct enzymatic inhibitory activity despite demonstrating therapeutic efficacy in vivo. Such discrepancies highlight the necessity of understanding systemic transformation processes before clinical application. This study addresses the lack of comparative data across multiple species to clarify the prevalence of this inversion phenomenon.

Keywords:
NSAID metabolismchiral inversionanalgesic efficacyenantiomer conversion

Frequently Asked Questions

The researchers propose that the (R)-enantiomer functions as a prodrug, converting into the active (S)-enantiomer in vivo. This transformation allows the otherwise inactive (R)-form to exert analgesic effects comparable to the (S)-form in mice and rats.

The study utilized eight distinct animal species to evaluate the metabolic conversion, ranging from gerbils, which showed 27% inversion, to dogs, which exhibited 73% inversion after one hour.

The researchers administered the drug orally at a dosage of 20 mg/kg. This specific concentration was necessary to observe the systemic conversion of the (R)-enantiomer into the (S)-enantiomer across all tested models.

Plasma samples collected at one and three hours post-administration provided the data. These time points allowed the team to track the persistence and increase of the (S)-enantiomer levels over time.

Related Experiment Videos

Purpose Of The Study:

The aim of this study was to evaluate the metabolic inversion of the (R)-enantiomer of ketoprofen into the (S)-enantiomer across eight different animal species. Researchers sought to clarify whether this chemical transformation accounts for the observed therapeutic efficacy of the (R)-isomer. The study addressed the uncertainty regarding the extent of this conversion in diverse mammalian models. No prior work had resolved how consistently this inversion occurs across such a broad range of species. The team investigated the potential for the (R)-isomer to function as a prodrug for the active (S)-form. This research was motivated by the observation that the (R)-isomer lacks direct inhibitory activity against cyclooxygenase. By comparing the analgesic effects of both isomers, the authors aimed to determine the role of metabolic conversion in drug performance. This investigation provides a comprehensive assessment of the pharmacokinetic behavior of this specific non-steroidal anti-inflammatory drug.

Main Methods:

Review approach involved administering the (R)-enantiomer orally to eight distinct animal species at a fixed dosage of 20 mg/kg. The investigation focused on quantifying the conversion rate into the (S)-enantiomer within plasma samples. Researchers collected blood specimens at one hour and three hours post-dosing to monitor metabolic changes. The team employed standard analgesic assays in mice and rats to evaluate the therapeutic impact of the administered isomer. This design allowed for a direct comparison of the pharmacological effects between the two enantiomers. The methodology prioritized tracking the persistence of the inversion process over the specified time intervals. By comparing the results across multiple species, the study established a broad overview of this metabolic pathway. The approach ensured that the findings reflected systemic transformation rather than localized drug activity.

Main Results:

Key findings from the literature demonstrate that a significant degree of inversion occurred in all eight species tested. The conversion rate ranged from 27% in the gerbil to 73% in the dog after one hour. Plasma analysis confirmed that this transformation persisted or increased by the three-hour mark. The (R)-enantiomer showed no activity as an inhibitor of cyclooxygenase in the experimental conditions. Despite this lack of enzymatic inhibition, the (R)-isomer produced analgesic effects nearly identical to the (S)-isomer in mice and rats. These results indicate that the (R)-form serves as a precursor for the active (S)-form. The data show that the inversion process is a consistent feature across the diverse mammalian models examined. The findings provide clear evidence that the therapeutic outcomes are driven by the production of the (S)-enantiomer.

Conclusions:

The authors propose that the (R)-enantiomer acts primarily as a precursor for the active (S)-form under the tested experimental parameters. Synthesis and implications suggest that the observed analgesic efficacy stems from this systemic conversion rather than direct activity of the administered isomer. The researchers note that the degree of transformation varies substantially across the eight examined species. These findings indicate that metabolic inversion is a widespread biological process among the tested mammals. The study implies that the therapeutic profile of the drug is heavily dependent on the rate of this chemical change. The authors suggest that the conversion process remains active for several hours following initial ingestion. These results support the classification of the (R)-isomer as a prodrug in these specific animal models. The evidence confirms that the pharmacological impact is mediated through the production of the (S)-enantiomer in vivo.

The team measured the percentage of inversion, which varied from 27% in the gerbil to 73% in the dog. This measurement confirmed the occurrence of the chemical change in all subjects.

The authors suggest that the observed analgesic efficacy in animal assays is largely attributable to the conversion of the (R)-isomer into the (S)-isomer. This implies that the (R)-form lacks direct cyclooxygenase inhibitory activity.